pEPito: a significantly improved non-viral episomal expression vector for mammalian cells

<p>Abstract</p> <p>Background</p> <p>The episomal replication of the prototype vector pEPI-1 depends on a transcription unit starting from the constitutively expressed <it>Cytomegalovirus </it>immediate early promoter (CMV-IEP) and directed into a 2000 bp lo...

Full description

Bibliographic Details
Main Authors: Ogris Manfred, Lipps Hans J, Harbottle Richard P, Wong Suet-Ping, Argyros Orestis, Haase Rudolf, Magnusson Terese, Pinto Maria, Haas Jürgen, Baiker Armin
Format: Article
Language:English
Published: BMC 2010-03-01
Series:BMC Biotechnology
Online Access:http://www.biomedcentral.com/1472-6750/10/20
_version_ 1828259343233974272
author Ogris Manfred
Lipps Hans J
Harbottle Richard P
Wong Suet-Ping
Argyros Orestis
Haase Rudolf
Magnusson Terese
Pinto Maria
Haas Jürgen
Baiker Armin
author_facet Ogris Manfred
Lipps Hans J
Harbottle Richard P
Wong Suet-Ping
Argyros Orestis
Haase Rudolf
Magnusson Terese
Pinto Maria
Haas Jürgen
Baiker Armin
author_sort Ogris Manfred
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>The episomal replication of the prototype vector pEPI-1 depends on a transcription unit starting from the constitutively expressed <it>Cytomegalovirus </it>immediate early promoter (CMV-IEP) and directed into a 2000 bp long <it>matrix attachment region sequence </it>(MARS) derived from the human β-interferon gene. The original pEPI-1 vector contains two mammalian transcription units and a total of 305 CpG islands, which are located predominantly within the vector elements necessary for bacterial propagation and known to be counterproductive for persistent long-term transgene expression.</p> <p>Results</p> <p>Here, we report the development of a novel vector pEPito, which is derived from the pEPI-1 plasmid replicon but has considerably improved efficacy both <it>in vitro </it>and <it>in vivo</it>. The pEPito vector is significantly reduced in size, contains only one transcription unit and 60% less CpG motives in comparison to pEPI-1. It exhibits major advantages compared to the original pEPI-1 plasmid, including higher transgene expression levels and increased colony-forming efficiencies <it>in vitro</it>, as well as more persistent transgene expression profiles <it>in vivo</it>. The performance of pEPito-based vectors was further improved by replacing the CMV-IEP with the <it>human CMV enhancer/human elongation factor 1 alpha promoter </it>(hCMV/EF1P) element that is known to be less affected by epigenetic silencing events.</p> <p>Conclusions</p> <p>The novel vector pEPito can be considered suitable as an improved vector for biotechnological applications <it>in vitro </it>and for non-viral gene delivery <it>in vivo</it>.</p>
first_indexed 2024-04-13T03:07:19Z
format Article
id doaj.art-43c95a8b7eb741b6bad7097d49fa8c27
institution Directory Open Access Journal
issn 1472-6750
language English
last_indexed 2024-04-13T03:07:19Z
publishDate 2010-03-01
publisher BMC
record_format Article
series BMC Biotechnology
spelling doaj.art-43c95a8b7eb741b6bad7097d49fa8c272022-12-22T03:05:12ZengBMCBMC Biotechnology1472-67502010-03-011012010.1186/1472-6750-10-20pEPito: a significantly improved non-viral episomal expression vector for mammalian cellsOgris ManfredLipps Hans JHarbottle Richard PWong Suet-PingArgyros OrestisHaase RudolfMagnusson TeresePinto MariaHaas JürgenBaiker Armin<p>Abstract</p> <p>Background</p> <p>The episomal replication of the prototype vector pEPI-1 depends on a transcription unit starting from the constitutively expressed <it>Cytomegalovirus </it>immediate early promoter (CMV-IEP) and directed into a 2000 bp long <it>matrix attachment region sequence </it>(MARS) derived from the human β-interferon gene. The original pEPI-1 vector contains two mammalian transcription units and a total of 305 CpG islands, which are located predominantly within the vector elements necessary for bacterial propagation and known to be counterproductive for persistent long-term transgene expression.</p> <p>Results</p> <p>Here, we report the development of a novel vector pEPito, which is derived from the pEPI-1 plasmid replicon but has considerably improved efficacy both <it>in vitro </it>and <it>in vivo</it>. The pEPito vector is significantly reduced in size, contains only one transcription unit and 60% less CpG motives in comparison to pEPI-1. It exhibits major advantages compared to the original pEPI-1 plasmid, including higher transgene expression levels and increased colony-forming efficiencies <it>in vitro</it>, as well as more persistent transgene expression profiles <it>in vivo</it>. The performance of pEPito-based vectors was further improved by replacing the CMV-IEP with the <it>human CMV enhancer/human elongation factor 1 alpha promoter </it>(hCMV/EF1P) element that is known to be less affected by epigenetic silencing events.</p> <p>Conclusions</p> <p>The novel vector pEPito can be considered suitable as an improved vector for biotechnological applications <it>in vitro </it>and for non-viral gene delivery <it>in vivo</it>.</p>http://www.biomedcentral.com/1472-6750/10/20
spellingShingle Ogris Manfred
Lipps Hans J
Harbottle Richard P
Wong Suet-Ping
Argyros Orestis
Haase Rudolf
Magnusson Terese
Pinto Maria
Haas Jürgen
Baiker Armin
pEPito: a significantly improved non-viral episomal expression vector for mammalian cells
BMC Biotechnology
title pEPito: a significantly improved non-viral episomal expression vector for mammalian cells
title_full pEPito: a significantly improved non-viral episomal expression vector for mammalian cells
title_fullStr pEPito: a significantly improved non-viral episomal expression vector for mammalian cells
title_full_unstemmed pEPito: a significantly improved non-viral episomal expression vector for mammalian cells
title_short pEPito: a significantly improved non-viral episomal expression vector for mammalian cells
title_sort pepito a significantly improved non viral episomal expression vector for mammalian cells
url http://www.biomedcentral.com/1472-6750/10/20
work_keys_str_mv AT ogrismanfred pepitoasignificantlyimprovednonviralepisomalexpressionvectorformammaliancells
AT lippshansj pepitoasignificantlyimprovednonviralepisomalexpressionvectorformammaliancells
AT harbottlerichardp pepitoasignificantlyimprovednonviralepisomalexpressionvectorformammaliancells
AT wongsuetping pepitoasignificantlyimprovednonviralepisomalexpressionvectorformammaliancells
AT argyrosorestis pepitoasignificantlyimprovednonviralepisomalexpressionvectorformammaliancells
AT haaserudolf pepitoasignificantlyimprovednonviralepisomalexpressionvectorformammaliancells
AT magnussonterese pepitoasignificantlyimprovednonviralepisomalexpressionvectorformammaliancells
AT pintomaria pepitoasignificantlyimprovednonviralepisomalexpressionvectorformammaliancells
AT haasjurgen pepitoasignificantlyimprovednonviralepisomalexpressionvectorformammaliancells
AT baikerarmin pepitoasignificantlyimprovednonviralepisomalexpressionvectorformammaliancells